The global Angioplasty Balloon Market size is expected to reach USD 2.9 billion by 2025, according to a new report by Grand View Research, Inc. The market is projected to record a CAGR of 3.3% during the forecast period. This growth is attributed to favorable government policies and increasing coronary and peripheral interventions. Angioplasty is a minimally invasive procedure, hence patients and surgeons prefer this procedure over high-cost stent placements. Furthermore, advancements in angioplasty balloons and expanding geographical reach are likely to propel the market growth in the coming years.

For instance, in December 2014, Medtronic plc received an FDA approval for their drug-coated balloon IN.PACT Admiral for the treatment of peripheral artery disease. The company also received product approval from Japanese Ministry of Health, Labor and Welfare for the treatment of peripheral artery disease in the upper leg. Approval and commercialization of cutting and scoring balloons, such as TREK and MINI TREK, AngioSculpt, and Flextome balloons along with rising adoption of new balloons are likely to drive the market further.

To request a sample copy or view summary of this report, click the link below: 
https://www.grandviewresearch.com/industry-analysis/angioplasty-balloons-market

Further key findings from the study suggest:

• Normal balloon segment led the market in 2017 due to low costs and ability of these products to treat coronary artery obstruction
• DEBs are anticipated to be the fastest-growing segment during the forecast period due to lower restenosis rate and increased R&D investments by major companies
• Coronary vascular disease segment led in 2017 and is expected to maintain its dominance during the forecast period due to rising cases of coronary artery diseases
• Ambulatory surgery centers (ASCs) led the end use segment in 2017 as they help minimize the medical expenses and hospital stay
• North America was the dominant regional market the market in 2017 and is expected to maintain its position during the forecast period due to the presence of major companies
• Asia Pacific is anticipated to be the fastest-growing region during the forecast period due to rising healthcare expenditure and R&D investments by key companies
• Some of the prominent companies in the industry are Abbott Laboratories; Boston Scientific Corp.; Cardinal Health (Cordis); Cook Medical, Inc.; Becton Dickinson. and Company (C.R. Bard); ENDOCOR GmbH; Medtronic PLC; Spectranetics Corp.; and Johnson & Johnson

Angioplasty balloon is a medical device that is used for surgical widening or unblocking of a blood vessel, especially a coronary artery. A noticeable increase in health conditions have been is observed due to some factors that cause heart related diseases such as obesity, poor diet, and extra cholesterol. .Coronary artery disease is a life threatening disease which occurs due to insufficient supply of blood to the heart, leading to cardiac arrest. Thus, a person experiencing such medical condition should be treated with angioplasty procedure, which cleans the narrow and blocked blood veins. Angioplasty includes insertion of a small balloon tipped catheter into the blood vessel, which is then inflated at the site of blockage to help open the narrowed arteries.

Click To Continue Reading on Angioplasty Balloons Market

According to the health protection agency survey 2016, around 610,000 people die every year in the U.S. due to heart defects and this number is still on an upsurge. According to World Health Organizations (WHO) 2011, around 8 million individuals suffering from peripheral artery disease were recorded in the U.S. Coronary heart disease is a major cause of all the deaths in the country, which accounted for around 45% of total deaths. The prevalence of these diseases are expected to increase over the forecast period.

Moreover, the growing ageing population experiencing heart ailments and diabetes, is expected to create higher demand angioplasty balloon catheters over the forecast period.

Increasing number of cardiovascular disease such as peripheral disease, coronary heart disease, and diabetes increase the global market value of angioplasty balloon. However, increase in number of key players of angioplasty balloon market has resulted in price conflicts, which is expected to curb growth of the global market.

Rise in the demand for angioplasty balloon in North America, makes it a global leader.

According to world health organizations (WHO) 2014, the North America angioplasty balloon market is predicted to reach 38% of global market share during next decade. According to the same reports, around 3.4 million people in North America are suffering from cardiovascular diseases. The growing healthcare facilities involving angioplasty in this region, have contributed to market growth. Moreover, the North American region is also a center of technological advancements and inventions of new products for catheters and angioplasty balloon, which further helps boost the market for angioplasty balloon. This makes North America a global leader of angioplasty balloon market.

According to the World Health Organizations reports (WHO) 2016, European region was the second leading global market for angioplasty balloon usage, due to the presence of large geriatric population suffering from cardiovascular diseases in the region. However, Asia Pacific region is expected to lead and emerge as the leading global user for angioplasty balloon over the forecast period. This is due to the world’s largest population present in this region with a noticeable number of people suffering from heart diseases. The costs of angioplasty balloon has decreased by around 40% in over recent decade in India, Japan, and China, which is significantly indicates growth of the angioplasty balloon market in Asia-Pacific.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/742

Key Vendors:

NATEC Medical, Cook Medical, Medtronic plc, C.R. Bard Inc., Boston Scientific Corporation, Spectranetics Corporation, ENDOCOR GmbH, BIOTRONIK SE & CO. KG, Cordis Corporation, Abbott Laboratories, and Opto Circuits Ltd..

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email: sales@coherentmarketinsights.com

Visit our news Website: https://www.coherenttimes.org/